Company Filing History:
Years Active: 2017
Title: The Innovations of Christophe Rochais
Introduction
Christophe Rochais is a notable inventor based in Caen, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific receptors in the human body. His work has implications for various therapeutic applications.
Latest Patents
Rochais holds a patent for "Acetylcholinesterase inhibitors and promnesiant serotonin 5-HT4 receptor agonists, their methods of preparation and the pharmaceutical compositions containing the same." This patent includes compounds represented by Formula (I) along with their enantiomers, racemics, acid salts, hydrates, and solvation products. The invention details methods for preparing these compounds and the pharmaceutical compositions that incorporate them.
Career Highlights
Throughout his career, Christophe Rochais has been associated with esteemed institutions such as Université de Caen. His research has focused on innovative approaches to drug development, particularly in the realm of neuropharmacology.
Collaborations
Rochais has collaborated with notable colleagues, including Patrick Dallemagne and Cedric Lecoutey. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical compounds.
Conclusion
Christophe Rochais is a prominent figure in the field of pharmaceutical innovation, with a focus on developing compounds that have the potential to improve therapeutic outcomes. His contributions continue to influence the landscape of drug development.